Amgen hires head of Europe from Roche
June 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Corinne Le Goff, Roche
Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …
NICE Lynparza rejection labelled ‘hard to understand’
June 2, 2015Sales and Marketing AstraZeneca, NICE, lynparza, olaparib
AstraZeneca has appealed to the government to put ‘urgent transitional measures’ in place to make sure patients can access innovative …
AstraZeneca lung drug shines on
June 1, 2015Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar
AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …
BMS immunotherapy combination impresses at ASCO
June 1, 2015Research and Development, Sales and Marketing ASCO, BMS, Yervoy, opdivo
Bristol-Myers Squibb has presented data showing that a combination of its immunotherapies Opdivo and Yervoy significantly increases survival in advanced …
Pfizer breast cancer drug delivers
June 1, 2015Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells
A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …
Former GSK Oncology president joins Kesios
June 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, kesios
The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …
Searching for new biotech solutions
June 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Emily Drabant Conley, google
For pharma, the elevator pitch for 23andMe is an intriguing prospect. It has the largest genetic database in the world, …
BMS’ Opdivo improves lung cancer survival
May 29, 2015Research and Development, Sales and Marketing ASCO, BMS, Bristol-Myers Squibb, NSCLC, lung cancer, nivolumab, non-small cell lung cancer, opdivo
A Phase III trial of Bristol-Myers Squibb’s immunotherapy Opdivo has found it increases overall survival in people with a common …
NICE green-light for Novartis skin drug
May 29, 2015Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab
NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …
Lilly and AstraZeneca collaborate on cancer trials
May 29, 2015Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I
AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …
Pfizer gets first approval for rare lung disease
May 29, 2015Sales and Marketing FDA, Pfizer, Rapamune, lung disease
Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …
Teva settles generic ‘pay-to-delay’ case for $1.2 billion
May 29, 2015Sales and Marketing Cephalon, FTC, Teva, modafinil, provigil
Teva Pharmaceuticals has agreed to a $1.2 billion settlement for paying generic drug makers to delay challenging the patent for …
Sanofi plays host to German chancellor Angela Merkel
May 29, 2015Manufacturing and Production, Medical Communications, Sales and Marketing France, Germany, Sanofi, angela, brett wells, merkel
German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …
Huntingdon and Harlan names corporate marketing VP
May 29, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntingdon and Harlan, joseph bedford
UK’s Huntingdon Life Sciences and Harlan Laboratories has appointed Dr Joseph Bedford to serve as corporate vice president of global …
Two new diabetes drugs approved
May 28, 2015Sales and Marketing Japan, Takeda, diabetes in China, lilly
Two new diabetes offerings from Lilly and Takeda are now available for patients in the US and Japan after they …
Eisai seeks new ALS drug approval
May 28, 2015Sales and Marketing Eisai, Japan, als, mecobalamin
Eisai is hoping that existing neurology drug mecobalamin can be a new option for the difficult-to-treat condition amyotrophic lateral sclerosis …
Actavis and Valeant see FDA approval for IBS drugs
May 28, 2015Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells
Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …
NICE sets out office for market access plans
May 28, 2015Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access
The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …
Kayentis names four committee members
May 28, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Patrizia Paterlini-Brechot, Pierre-Olivier Goineau, Ronan Roussel, Stephen Senn, kayentis
French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans. Accepting director Guillaume …
Another Chinese health official arrested for corruption
May 27, 2015Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu
A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
